Elson C E
Department of Nutritional Sciences, University of Wisconsin, Madison 53706.
Crit Rev Food Sci Nutr. 1992;31(1-2):79-102. doi: 10.1080/10408399209527562.
Individually and in combination with other oils, the tropical oils impart into manufactured foods functional properties that appeal to consumers. The use of and/or labeling in the ingredient lists give the impression that these oils are used extensively in commercially processed foods. The estimated daily intake of tropical oils by adult males is slightly more than one fourth of a tablespoon (3.8 g), 75% of which consists of saturated fatty acids. Dietary fats containing saturated fatty acids at the beta-position tend to raise plasma total and LDL-cholesterol, which, of course, contribute to atherosclerosis and coronary heart disease. Health professionals express concern that consumers who choose foods containing tropical oils unknowingly increase their intake of saturated fatty acids. The saturated fatty acid-rich tropical oils, coconut oil, hydrogenated coconut oil, and palm kernel oil, raise cholesterol levels; studies demonstrating this effect are often confounded by a developing essential fatty acid deficiency. Palm oil, an essential fatty acid-sufficient tropical oil, raises plasma cholesterol only when an excess of cholesterol is presented in the diet. The failure of palm oil to elevate blood cholesterol as predicted by the regression equations developed by Keys et al. and Hegsted et al. might be due to the dominant alpha-position location of its constituent saturated fatty acids. If so, the substitution of interesterified artificial fats for palm oil in food formulations, a recommendation of some health professionals, has the potential of raising cholesterol levels. A second rationale addresses prospective roles minor constituents of palm oil might play in health maintenance. This rationale is founded on the following observations. Dietary palm oil does not raise plasma cholesterol. Single fat studies suggests that oils richer in polyunsaturated fatty acid content tend to decrease thrombus formation. Anomalously, palm oil differs from other of the more saturated fats in tending to decrease thrombus formation. Finally, in studies comparing palm oil with other fats and oils, experimental carcinogenesis is enhanced both by vegetable oils richer in linoleic acid content and by more highly saturated animal fats. The carotenoid constituents of red palm oil are potent dietary anticarcinogens. A second group of antioxidants, the tocotrienols, are present in both palm olein and red palm oil. These vitamin E-active constituents are potent suppressors of cholesterol biosynthesis; emerging data point to their anticarcinogenic and antithrombotic activities. This review does not support claims that foods containing palm oil have no place in a prudent diet.
热带油类单独使用或与其他油类混合使用时,能赋予加工食品一些吸引消费者的功能特性。在成分列表中的使用情况和/或标签给人一种印象,即这些油类在商业加工食品中被广泛使用。成年男性热带油类的估计每日摄入量略多于四分之一汤匙(3.8克),其中75%由饱和脂肪酸组成。在β位含有饱和脂肪酸的膳食脂肪往往会提高血浆总胆固醇和低密度脂蛋白胆固醇水平,这当然会导致动脉粥样硬化和冠心病。健康专家担心,选择含有热带油类食品的消费者会在不知不觉中增加饱和脂肪酸的摄入量。富含饱和脂肪酸的热带油类,如椰子油、氢化椰子油和棕榈仁油,会升高胆固醇水平;证明这种效果的研究常常因出现必需脂肪酸缺乏而受到干扰。棕榈油是一种富含必需脂肪酸的热带油类,只有在饮食中摄入过量胆固醇时才会升高血浆胆固醇。棕榈油未能如基斯等人和黑格斯特德等人建立的回归方程所预测的那样升高血液胆固醇,可能是由于其组成饱和脂肪酸主要处于α位。如果是这样,一些健康专家建议在食品配方中用酯交换人造脂肪替代棕榈油,这有可能会升高胆固醇水平。第二个理由涉及棕榈油中的微量成分在维持健康方面可能发挥的潜在作用。这个理由基于以下观察结果。食用棕榈油不会升高血浆胆固醇。单项脂肪研究表明,富含多不饱和脂肪酸的油类往往会减少血栓形成。反常的是,棕榈油与其他饱和度更高的脂肪不同,它往往会减少血栓形成。最后,在将棕榈油与其他油脂进行比较的研究中,富含亚油酸的植物油和饱和度更高的动物脂肪都会增强实验性致癌作用。红棕榈油中的类胡萝卜素成分是强大的膳食抗癌剂。另一组抗氧化剂生育三烯酚存在于棕榈油精和红棕榈油中。这些具有维生素E活性的成分是胆固醇生物合成的有效抑制剂;新出现的数据表明它们具有抗癌和抗血栓形成活性。这篇综述并不支持含有棕榈油的食品在合理饮食中没有一席之地的说法。